Moreover, this study points to ET-1 and E-selectin as indicators of ongoing lung injury and the subsequent severity in RA-ILD+ and SSc-ILD+, respectively, helping to monitor disease progression and therapeutic responses. The gene discussed is SELE; the disease is interstitial lung disease.